BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7537879)

  • 1. The influence of gravidity on Down's syndrome screening with free beta hCG.
    Spencer K
    Prenat Diagn; 1995 Jan; 15(1):87-9. PubMed ID: 7537879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
    Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
    Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
    Wald NJ; Watt HC
    Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of gravidity on maternal serum markers for Down's syndrome.
    Barkai G; Goldman B; Ries L; Chaki R; Cuckle H
    Prenat Diagn; 1996 Apr; 16(4):319-22. PubMed ID: 8734805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of free beta-hCG in antenatal screening for Down's syndrome.
    Wald N; Densem J; Stone R; Cheng R
    Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
    Hsu JJ; Hsieh TT; Soong YK; Spencer K
    Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
    Wald NJ; Densem JW
    Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-marker serum screening for Down's syndrome.
    Wald NJ; Densem JW; Smith D; Klee GG
    Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
    Watt HC; Wald NJ; Smith D; Kennard A; Densem J
    Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
    Spencer K; Salonen R; Muller F
    Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal serum free alpha- and free beta-human chorionic gonadotrophin in pregnancies with insulin-dependent diabetes mellitus: implications for screening for Down's syndrome.
    Wald NJ; Densem JW; Cheng R; Collishaw S
    Prenat Diagn; 1994 Sep; 14(9):835-7. PubMed ID: 7531328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome.
    Macri JN; Spencer K; Garver K; Buchanan PD; Say B; Carpenter NJ; Muller F; Boué A
    Prenat Diagn; 1994 Feb; 14(2):97-103. PubMed ID: 7514291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum screening for Down's syndrome.
    Bibby J; McCormack MJ
    Br J Obstet Gynaecol; 1994 Jun; 101(6):557-8. PubMed ID: 7517183
    [No Abstract]   [Full Text] [Related]  

  • 14. Maternal serum screening for chromosome defects: human chorionic gonadotropin versus its free-beta subunit.
    Milunsky A; Nebiolo LM; Bellet D
    Fetal Diagn Ther; 1993; 8(4):221-4. PubMed ID: 7505085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of parity on human chorionic gonadotrophin levels and Down's syndrome screening.
    Haddow JE; Palomaki GE; Knight GJ
    J Med Screen; 1995; 2(1):28-30. PubMed ID: 7497141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of maternal serum for fetal Down's syndrome in the first trimester.
    Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
    N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of smoking and parity on serum markers for Down's syndrome screening.
    Tislarić D; Brajenović-Milić B; Ristić S; Latin V; Zuvić-Butorac M; Bacić J; Petek M; Kapović M
    Fetal Diagn Ther; 2002; 17(1):17-21. PubMed ID: 11803210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
    Spencer K; Aitken DA; Macri JN; Buchanan PD
    Prenat Diagn; 1996 Jul; 16(7):605-13. PubMed ID: 8843469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. International Prenatal Screening Research Group.
    Wald NJ; George L; Smith D; Densem JW; Petterson K
    Br J Obstet Gynaecol; 1996 May; 103(5):407-12. PubMed ID: 8624312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.